ClinicalTrials.gov
ClinicalTrials.gov Menu

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00437684
Recruitment Status : Unknown
Verified February 2009 by IRCCS San Raffaele.
Recruitment status was:  Recruiting
First Posted : February 21, 2007
Last Update Posted : February 6, 2009
Sponsor:
Collaborators:
Abbott
Hoffmann-La Roche
Information provided by:
IRCCS San Raffaele

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : July 2010
  Estimated Study Completion Date : December 2010